Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data validation
1.4 Data collection
1.5 Forecast parameters
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising prevalence of brain diseases
3.2.1.2 Growing awareness regarding mental health issues
3.2.1.3 Increasing adoption of natural and herbal health products
3.2.1.4 Increase in geriatric population
3.2.2 Industry pitfalls & challenges
3.2.2.1 Side effects associated with supplements
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter’s analysis
3.5.1 Supplier power
3.5.2 Buyer power
3.5.3 Threat of new entrants
3.5.4 Threat of substitutes
3.5.5 Industry rivalry
3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Natural molecules
5.2.1 Acetyl-L-carnitine
5.2.2 Alpha-GPC
5.2.3 Citicoline
5.2.4 Docosahexaenoic acid (DHA)
5.2.5 Pre/pro/postbiotics
5.2.6 Other natural molecules
5.3 Herbal extract
5.3.1 Ginseng
5.3.2 Gingko biloba
5.3.3 Curcumin
5.3.4 Other herbal extracts
5.4 Vitamins & minerals
5.4.1 Vitamin B
5.4.2 Vitamin C & E
5.4.3 Other vitamins & minerals
Chapter 6 Market Estimates and Forecast, By Supplement Form, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Tablets
6.3 Capsules
6.4 Other supplement forms
Chapter 7 Market Estimates and Forecast, By Age Group, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Pediatric
7.3 Adult
7.4 Geriatric
Chapter 8 Market Estimates and Forecast, By Medication Type, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Prescription
8.3 OTC
Chapter 9 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 Memory enhancement
9.3 Attention & focus
9.4 Depression & mood
9.5 Sleep & recovery
9.6 Anti-aging & longevity
9.7 Stress & anxiety
Chapter 10 Market Estimates and Forecast, By Distribution Channel, 2018 – 2032 ($ Mn)
10.1 Key trends
10.2 Supermarkets & hypermarkets
10.3 Drug stores
10.4 Online stores
10.5 Other distribution channels
Chapter 11 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
11.1 Key trends, by region
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Accelerated Intelligence Inc.
12.2 Alternascript
12.3 HVMN Inc.
12.4 Intelligent Labs
12.5 Natural Factors USA
12.6 NOW Foods
12.7 Onnit Labs, Inc.
12.8 Purelife Bioscience Co., Ltd
12.9 Quincy Bioscience
12.10 Reckitt Benckiser Group PLC
12.11 Teva Pharmaceutical Industries Ltd.
